Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Crescent Biopharma (CBIO) Asset Utilization Ratio (2016 - 2025)

Crescent Biopharma (CBIO) has disclosed Asset Utilization Ratio for 8 consecutive years, with 0.0 as the latest value for Q1 2023.

  • On a quarterly basis, Asset Utilization Ratio rose 4.69% to 0.0 in Q1 2023 year-over-year; TTM through Mar 2023 was 0.0, a 4.69% increase, with the full-year FY2023 number at 0.0, down 79.94% from a year prior.
  • Asset Utilization Ratio was 0.0 for Q1 2023 at Crescent Biopharma, down from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.07 in Q4 2020 to a low of 0.0 in Q1 2022.
  • A 4-year average of 0.02 and a median of 0.01 in 2021 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: plummeted 92.49% in 2022, then rose 4.69% in 2023.
  • Crescent Biopharma's Asset Utilization Ratio stood at 0.07 in 2020, then tumbled by 83.46% to 0.01 in 2021, then tumbled by 87.86% to 0.0 in 2022, then decreased by 10.73% to 0.0 in 2023.
  • Per Business Quant, the three most recent readings for CBIO's Asset Utilization Ratio are 0.0 (Q1 2023), 0.0 (Q4 2022), and 0.0 (Q3 2022).